Author:
Mirone Giovanna,Shukla Arvind,Marfe Gabriella
Reference144 articles.
1. The vascular endothelial growth factor family; proteins which guide the development of the vasculature;Achen;Int. J. Exp. Pathol.,1998
2. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer;Amado;J. Clin. Oncol.,2008
3. The epidermal growth factor receptor: from mutant oncogene in non human cancers to therapeutic target in human neoplasia;Arteaga;J. Clin. Oncol.,2001
4. Association of K-ras status with efficacy end points from a phase 1/2 study of brivanib in combination with cetuximab in patients with advanced or metastatic colorectal cancer (CRC);Ayers,2009
5. Expression is associated with PIK3CA mutation, low stage and favorable outcome in 717 colorectal cancers;Baba;Cancer,2011
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献